Prevalence, clinical manifestations, etiology, and treatment of depression in parkinson's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 13, Issue 2, 2001, Pages 187-196

  Slaughter, J R ^a   Slaughter, K A ^a   Nichols, D ^a   Holmes, S E ^a   Martens, M P ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

AMNESIA; APATHY; ARTICLE; DEPRESSION; HUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; SUICIDAL BEHAVIOR;

EID: 0034980546     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.13.2.187     Document Type: Article

References (99)

1. The occurrence of depression in Parkinson's disease: A community-based study
2. An estimation of the incidence of depression in idiopathic Parkinson's disease
3. Depression and Parkinson's disease: A review
4. Parkinson's disease with depression: A possible subgroup of idiopathic parkinsonism
5. Parkinson's disease: A clinical study of one hundred and forty-six cases
6. Paralysis agitans: A clinical and genetic study
7. Imipramine in treatment of parkinsonism: A double-blind placebo study
8. Parkinsonism: Onset, progression, and mortality
9. Depressive symptoms in Parkinson patients referred for thalamotomy
10. Parkinsonism and depression
11. Psychiatric disturbances in Parkinson's disease
12. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations
13. Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disability
14. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy
15. Dementia in Parkinson disease
16. Psychiatric side-effects occurring in parkinsonism during long-term treatment with levodopa alone and in combination with other drugs
17. Depression intellectual impairment, and Parkinson disease
18. Depression and Parkinson's disease
19. Altered serotonin metabolism in depressed patients with Parkinson's disease
20. Mental disorders in Parkinson's disease after treatment with L-dopa
21. Depression in Parkinson's disease: A quantitative and qualitative analysis
22. Clinical and biochemical features of depression in Parkinson's disease
23. Cognitive functioning in Parkinson's disease: In relation to prevalence of dementia and psychiatric diagnosis
24. Mental depression in untreated Parkinson's disease of recent onset
25. Parkinson's disease and depression: A critical re-evaluation
26. Depression and Parkinson's disease: Possible role of serotonergic mechanisms
27. Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness: An experimental study
28. Depression and disability in Parkinson's disease: A follow-up of 132 cases
29. Depression in kinson's disease
30. An estimate of the prevalence of dementia in idiopathic Parkinson's disease
31. Depression type in Parkinson disease
32. Accuracy of self-reported disability in patients with parkinsonism
33. Patterns of adaptation to Parkinson's disease
34. Psychosocial factors in Parkinson's disease
35. Coexisting dementia and depression in Parkinson's disease
36. Depression in patients with early versus late onset of Parkinson's disease
37. Psychiatric morbidity in patients with Parkinson's disease
38. Depressive symptoms in Parkinson's disease: A comparison with disabled control subjects
39. The pattern of depressive symptoms varies with progression of Parkinson's disease
40. The premorbid personality of patients with Parkinson's disease: A comparative study with healthy controls and patients with essential tremor
41. The neuropathologic basis of different clinical subgroups of Parkinson's disease
42. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease
43. Antecedent clinical features associated with dementia in Parkinson's disease
44. Depression in Parkinson's disease
45. Effect of age at onset on frequency of depression in Parkinson's disease
46. Depression and disability in Parkinson's disease
47. Depression in multiple system atrophy and in idiopathic Parkinson's disease: A pilot comparative study
48. Depression in classic versus akinetic-rigid Parkinson's disease
49. Alterations in cognitive performance and effect-arousal during fluctuations in motor function in Parkinson's disease
50. Response choice in Parkinson's disease: The effects of uncertainty and stimulus-response compatibility
51. Depression in Parkinson's disease
52. Suicide in patients with Parkinson's disease: An epidemiological study
53. Mental disorders in Parkinson's disease
54. The effect of age and disease onset on neuropsychological performance in Parkinson's disease
55. Cognitive deficits in the early stages of Parkinson's disease
56. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician
57. The pre-morbid personality of patients with Parkinson's disease
58. The parkinsonian personality
59. Parkinson's disease in 65 pairs of twins and in a set of quadruplets
60. Parkinson's disease, personality, and dopamine
61. Personality and depression in Parkinson's disease
62. Premorbid personality and idiopathic Parkinson's disease
63. Dopamine-related personality traits in Parkinson's disease
64. Depression in Parkinson's disease: A qualitative and quantitative analysis
65. Depressive symptoms in Parkinson's disease: A comparison with disabled control subjects
66. Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: A controlled study
67. Depression in Parkinson's disease: A psychosocial viewpoint
68. Depressive symptoms in Parkinson patients referred for thalamotomy
69. Some psychological factors in parkinsonism
70. Dopamine and depression
71. Depression in Parkinson's disease: A biochemical and organic viewpoint
72. Quantitation of catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression
73. Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolites in patients with Parkinson's disease
74. Parkinson's disease with depression: A possible subgroup of idiopathic parkinsonism
75. Treatment of depression in Parkinson's disease: A meta-analysis
76. Drug treatment of depression in Parkinson's disease
77. Geriatric depression: Brain imaging correlates and pharmacologic considerations
78. Recent pharmacologic advances in antidepressant therapy for the elderly
79. A survey of antidepressant drug use in Parkinson's disease
80. New antidepressant drugs and the treatment of depression in the medically ill patient
81. A 61 year-old man with Parkinson's disease
82. Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease
83. Sertraline for the treatment of depression in Parkinson's disease
84. Depression in Parkinson's disease: Pharmacological characteristics and treatment
85. A risk-benefit assessment of mirtazapine in the treatment of depression
86. A double-blind comparison of nefazodone, imipramine, and placebo in major depression
87. Efficacy in long-term treatment of depression
88. A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression
89. ECT and Parkinson's disease revisited: A "naturalistic" study
90. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine
91. Bupropion in Parkinson's disease
92. Parkinson's disease worsened by nefazodone
93. Effects of electro-convulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems
94. ECT-induced delirium in depressed patients with Parkinson's disease
95. Development and validation of a geriatric depression screening scale: A preliminary report
96. Parkinson's disease in the elderly: Psychiatric manifestations
97. Suicide risk in Huntington's disease